LivingGLP1
Study S000425

Survey on the Current Status of Islet Alpha Cell Function in Patients with Type 2 Diabetes and Interventional Study of GLP-1RA: a Multicenter, Prospective Study

Registration

Registration
NCT06825182
Study type
INTERVENTIONAL
Phase
PHASE3
Masking
NONE
Status
RECRUITING
Enrollment
1000
Start
2024-11-07
Primary completion
2025-08-01
Lead sponsor
Nanjing First Hospital, Nanjing Medical University
Conditions
Type 2 Diabetes Mellitus
Interventions
DRUG:Outpatient newly diagnosed type 2 diabetes subjects; DRUG:Inpatient newly diagnosed type 2 diabetes subjects
Results posted
FALSE
Individual participant data sharing
NO

Registered primary outcomes

  • Glucagon levels [19 months]

Linked records (0)

Automatic links, confirmed or rejected during screening. A record citing this registration may be a secondary analysis, a commentary or a review that mentions the trial.

No records link to this registration yet.